APT Medical Inc. (SHA:688617)

Market Cap	41.77B
Revenue (ttm)	2.17B
Net Income (ttm)	716.16M
Shares Out	141.01M
EPS (ttm)	5.08
PE Ratio	58.35
Forward PE	46.52
Dividend	1.21 (0.41%)
Ex-Dividend Date	Jun 19, 2025

Volume	953,192
Average Volume	1,015,825
Open	291.99
Previous Close	291.50
Day's Range	284.35 - 297.50
52-Week Range	204.04 - 331.03
Beta	-0.35
RSI	63.45
Earnings Date	Aug 22, 2025

About APT Medical

APT Medical Inc. engages in the research, development, manufacturing, and supply of electrophysiology and vascular interventional medical devices in China. The company offers electrophysiological products comprising mapping catheters, ablation catheters, transseptal needle and sheaths, and steerable sheaths; and interventional cardiology and peripheral intervention products, such as introducer kits, guiding extension catheters, balloon catheters, guiding catheters, microcatheters, guidewires, hydrophilic angiographic catheters, hydrophilic guid...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2002
• Employees: 2,555
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688617

Financial Performance

In 2024, APT Medical's revenue was 2.07 billion, an increase of 25.18% compared to the previous year's 1.65 billion. Earnings were 673.15 million, an increase of 26.08%.